Monthly Sales Results, Upcoming Conference Calls, and Scholarship Programs - Analyst Notes on Walgreens, McKesson, Rite Aid, Cardinal Health and AmerisourceBergen

NEW YORK, July 16, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Walgreen Company (NYSE: WAG), McKesson Corporation (NYSE: MCK), Rite Aid Corporation (NYSE: RAD), Cardinal Health, Inc. (NYSE: CAH) and AmerisourceBergen Corporation (NYSE: ABC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4837-100free.

--
Walgreen Company Analyst Notes
On July 3, 2014, Walgreen Company (Walgreens) reported that its June 2014 sales increased by 8.9% YoY to $6.28 billion. Total front-end sales increased 1.8% YoY during the month, while comparable store front-end sales increased 1.3%. However, customer traffic in comparable stores decreased 2.0% while basket size increased 3.3%. Despite this, pharmacy sales during the month increased 13.4%, and comparable store pharmacy sales increased 11.3%. Further, calendar 2014 year-to-date sales for the first six months increased by 5.9% YoY to $38.13 billion, while FY 2014 year-to-date sales for the first 10 months registered a 6.0% YoY increase to $63.65 billion. The full analyst notes on Walgreens are available to download free of charge at:

http://www.analystsreview.com/Jul-16-2014/WAG/report.pdf

--
McKesson Corporation Analyst Notes
On July 10, 2014, McKesson Corporation (McKesson) announced that it will release its Q1 FY 2015 financial results (period ended June 30, 2014) on Thursday, July 31, 2014 prior to the opening on the New York Stock Exchange. The Company informed that it will also hold a conference call on the same day at 8:30 a.m. ET (5:30 a.m.PT) wherein John Hammergren, Chairman and CEO, and James Beer, Executive Vice President and CFO, will review the results. McKesson stated that the live call and archive of the same will be available on its Investor Relations website. The full analyst notes on McKesson are available to download free of charge at:

http://www.analystsreview.com/Jul-16-2014/MCK/report.pdf

--
Rite Aid Corporation Analyst Notes
On July 11, 2014, Rite Aid Corporation's (Rite Aid) stock decreased 1.08%, ending the day at $7.30. Over the previous five trading sessions, shares of the Company decreased 3.57% compared with S&P 500, which also decreased 0.90% during the same trading period. The full analyst notes on Rite Aid are available to download free of charge at:

http://www.analystsreview.com/Jul-16-2014/RAD/report.pdf

--
Cardinal Health, Inc. Analyst Notes
On July 7, 2014, Cardinal Health, Inc. (Cardinal Health) announced that nine pharmacy schools across the country will collectively receive $2 million in funding through its Cardinal Health Pharmacy Scholarship Program in 2014. According to the Company, the schools selected were: Bill Gatton College of Pharmacy, East Tennessee State University; College of Pharmacy, The Ohio State University; McWhorter School of Pharmacy ,Samford University; College of Pharmacy and Health Sciences, Campbell University; Bouve College of Health Sciences, School of Pharmacy, Northeastern University; St. Louis College of Pharmacy; Harrison School of Pharmacy, Auburn University; Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific; and College of Pharmacy, Idaho State University. The Company stated that the schools were chosen based on their commitment to advance the independent pharmacy profession. Mike Kaufmann, CEO of Cardinal Health's Pharmaceutical segment, said, "We're proud to support tomorrow's community pharmacy leaders through this scholarship program, and we're inspired by the impact we know they'll have on their patients and communities, when they become pharmacy owners." The full analyst notes on Cardinal Health are available to download free of charge at:

http://www.analystsreview.com/Jul-16-2014/CAH/report.pdf

--
AmerisourceBergen Corporation Analyst Notes
On July 9, 2014, AmerisourceBergen Corporation (AmerisourceBergen) announced that it has scheduled to release its Q3 FY 2014 financial results on Thursday, July 24, 2014, prior to the opening of trading on the New York Stock Exchange, which will be followed by a conference call that same day at 11:00 a.m. ET. The Company informed that Steven H. Collis, President and CEO, and Tim G. Guttman, Senior Vice President and CFO, will be participating in the call. AmerisourceBergen added that the live webcast of the call and archive of the same for 30 days will be made available on its Investor Relations website. The full analyst notes on AmerisourceBergen are available to download free of charge at:

http://www.analystsreview.com/Jul-16-2014/ABC/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review